2365 Nanoliposomal irinotecan (MM-398, nal-IRI) population pharmacokinetics (PK) and its association with efficacy and safety in patients with solid tumors based on the phase 3 stu... by Ma, W.W, Chung, I, Lang, I, Csõszi, T, Wenczl, M.W, Cubillo, A, Chen, J, Wong, M, Park, J.O, Kim, J.S, Rau, K.M, Melichar, B, Gallego, J, Smakal, M, Kim, J, Belanger, B, Bayever, E, Adiwijaya, B

Get full text